Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 14 of 15
Lever Bio
Claris Biotech I
ItalySector
Biotech
InvestorClaris Ventures SGR
Entry
2025
Hold
1yr
Libra Therapeutics
Boehringer Ingelheim Venture Fund
United StatesSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2020
Hold
6yr
Lighthouse Biotech
Utopia SIS
ItalySector
Biotech
InvestorUtopia SIS
Entry
2021
Hold
5yr
Lutris Pharma
Columbus Life Sciences Fund III
Israel
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2025
Hold
1yr
Macro Biologics
Oscar & Paul Venture Capital Fund I
United StatesSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Mage Biologics, Inc.
TVM Life Science Innovation
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Mariposa Therapeutics
Development Bank of Wales (Balance Sheet)
UKSector
Biotech
InvestorDevelopment Bank of Wales
Entry
2026
Hold
0yr
MDTB Cell Manufacturing
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Melt&Marble
Oscar & Paul Venture Capital Fund I
SwedenSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2025
Hold
1yr
MeOmics Precision Medicine
Development Bank of Wales (Balance Sheet)
UKSector
Biotech
InvestorDevelopment Bank of Wales
Entry
2026
Hold
0yr
MoglingBio
KIZOO Evergreen (Balance Sheet)
GermanySector
Biotech
InvestorKIZOO Technology Capital
Entry
2022
Hold
4yr
Mogrify
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2021
Hold
5yr
Montara Therapeutics
Dementia Discovery Fund
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2024
Hold
2yr
Nanoligent
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2025
Hold
1yr
NeoEarth
First Imagine! Ventures
FranceSector
Biotech
InvestorFirst Imagine! Ventures
Entry
2025
Hold
1yr
Neomatrix S.r.l.
Deutsche Balaton Evergreen Holding (Balance Sheet)
ItalySector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2023
Hold
3yr
Neotis
Daphni Blue
FranceSector
Biotech
InvestorDaphni
Entry
2025
Hold
1yr
NeRRe Therapeutics
Columbus Life Science Fund II
United KingdomSector
Biotech
InvestorColumbus Venture Partners
Entry
2021
Hold
5yr
NetZeroNitrogen
Revent Fund I
United KingdomSector
Biotech
InvestorRevent
Entry
2023
Hold
3yr
neuway Pharma
Wellington Partners Life Sciences
GermanySector
Biotech
InvestorWellington Partners
Entry
2014
Hold
12yr
Nido Biosciences
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
NovaSAID
Rosetta Capital IV
SwedenSector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Novos
Unilever Ventures (Evergreen)
United StatesSector
Biotech
InvestorUnilever Ventures
Entry
2026
Hold
0yr
Nuvig Therapeutics
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
Ocellaris Pharma
TVM Life Science Innovation
Canada
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2019
Hold
7yr
Ochre Bio
Apollo Health Ventures Fund II
United KingdomSector
Biotech
InvestorApollo Health Ventures
Entry
2021
Hold
5yr
Opthea
Abingworth Clinical Co-Development Fund 2
Australia
Sector
Biotech
InvestorAbingworth
Entry
2022
Hold
4yr
Oriva Therapeutics
Sabadell Asabys Health Innovation Investments II
SpainSector
Biotech
InvestorAsabys Partners
Entry
2026
Hold
0yr
Oxford Biomedica
Vitruvian Investment Partnership IV
UKSector
Biotech
InvestorVitruvian Partners
Entry
2021
Hold
5yr
Oxford Cancer Analytics
Eka Ventures Fund I
UKSector
Biotech
InvestorEKA Ventures
Entry
2022
Hold
4yr
Oxolife
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2020
Hold
6yr
Pathalys Pharma
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
PDS Biotechnology
EMV Capital Evergreen Fund
United StatesSector
Biotech
InvestorEMV Capital
Entry
2014
Hold
12yr
PEPperPRINT
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2010
Hold
16yr
Pergamum
Rosetta Capital IV
SwedenSector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Phaeosynt GmbH
NBank Capital Beteiligungsfonds
GermanySector
Biotech
InvestorNBank Capital
Entry
2025
Hold
1yr
Pharmacelera
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2026
Hold
0yr
PharmEste
Principia Fund
ItalySector
Biotech
InvestorPrincipia SGR
Entry
2007
Hold
19yr
PL BioScience
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
GermanySector
Biotech
InvestorD11Z. Ventures
Entry
2021
Hold
5yr
Polyphron
Vento Fund II
United StatesSector
Biotech
InvestorVento
Entry
2025
Hold
1yr
Portal Biotech
Earlybird Health
United KingdomSector
Biotech
InvestorEarlybird Venture Capital
Entry
2025
Hold
1yr
PreOmics
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Promatix
ALSA Ventures European Biotechnology Fund
UKSector
Biotech
InvestorALSA Ventures
Entry
2021
Hold
5yr
Proteos Biotech
Tresmares Private Equity Fund II
SpainSector
Biotech
InvestorTresmares Capital
Entry
2023
Hold
3yr
ProTgen
Boehringer Ingelheim Venture Fund
United StatesSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
PsiOxus Therapeutics
Rosetta Capital V
UKSector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Pulmobiotics
Invivo Ventures
SpainSector
Biotech
InvestorInvivo Partners
Entry
2020
Hold
6yr
QUANTRO Therapeutics
Boehringer Ingelheim Venture Fund
AustriaSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2020
Hold
6yr
R1 Therapeutics
Abingworth Bioventures IX
USSector
Biotech
InvestorAbingworth
Entry
2026
Hold
0yr
Rathlin Therapeutics
Columbus Life Sciences Fund IV
United KingdomSector
Biotech
InvestorColumbus Venture Partners
Entry
2023
Hold
3yr